The Adeno-Associated Virus Gene Therapy Market was valued at approximately ~USD 2000 Million in 2023 and is expected to grow at a strong CAGR of around 39% during the forecast period (2024-2032) Several pharmaceutical companies is rapidly investing in research and development, thus driving the market growth during the forthcoming years. The high cost associated with the AAV gene therapy is one...

The Gene Therapy Market was valued at approximately USD 9.2 billion in 2024 and is expected to grow at a substantial CAGR of around 30.1% during the forecast period (2025-2033), owing to the growing gene therapy pipeline. Introduction North America, with its cutting-edge research institutions, innovative biotech companies, and robust healthcare infrastructure, stands at the forefront of the...

Gene Therapy Market Overview Imagine a world where cutting-edge tech transforms industries, boosts efficiency, and opens doors to endless innovation. That's the promise of the market, and according to Straits Research, it's on a rocket ship trajectory with a robust The global gene therapy market size was valued at USD 6.30 billion in 2024 and is projected to reach from USD...